1) reboxetine mesylate
甲磺酸瑞波西汀
1.
A randomized and double-blinded clinical trial of reboxetine mesylate for treatment of depression;
甲磺酸瑞波西汀治疗抑郁症的临床试验
2.
So,the completion of reboxetine mesylate synthesis and development of its intermediate synthetic route economically viably is quite necessary,and will have very good social and economic prospects.
甲磺酸瑞波西汀是新一代的去甲肾上腺素再摄取抑制剂,在抑郁症的治疗中表现出很好的药效和高耐受性。
2) Reboxetine
瑞波西汀
1.
Reboxetine Combined with Clozapine for Negative Symptoms of Schizophrenia:A Randomized Double-blind Controlled Study;
瑞波西汀合并氯氮平治疗精神分裂症阴性症状的随机双盲对照研究
2.
Effect of Reboxetine Combined with Clozapine on Negative Symptoms Quality of Life of the Patients with Schizophrenia;
瑞波西汀合并氯氮平对精神分裂症患者阴性症状和生活质量的影响
3.
Efficacy and Safety of Reboxetine in the Treatment of Depression;
甲磺酸瑞波西汀治疗抑郁症的疗效与安全性
3) Reboxitine
瑞波西汀
1.
ObjectiveTo explore the efficacy and side-effects of reboxitine on post-schizophrenic depression.
目的探讨用瑞波西汀(叶洛抒)治疗精神分裂症后抑郁的临床疗效和不良反应。
4) Betahistine mesylate
甲磺酸倍他司汀
1.
OBJECTIVE: To study the bioequivalence of domestic and imported betahistine mesylate in 20 healthy volunteers.
目的:对健康受试者单剂量口服国产和进口甲磺酸倍他司汀片后的药代动力学特性及生物等效性进行评价。
5) betahistine mesilate
甲磺酸倍他斯汀
6) renoquid
磺胺西汀
补充资料：甲磺酸齐拉西酮
分子式：C21H21ClN4OS.CH4O3S
分子量：509.04
CAS号：199191-69-0
性质：
分子量：509.04
CAS号：199191-69-0
性质：
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条